© Reuters. Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga - Gainers
- FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07.
- Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday.
- Applied UV, Inc. (NASDAQ: AUVI) gained 46.1% to $1.52 after the company announced that it has engaged a legal counsel to investigate potential illegal short selling of its stock.
- Quince Therapeutics, Inc. (NASDAQ: QNCX) gained 43% to $1.1686 after the company announced the sale of its legacy small molecule protease inhibitor portfolio to Lighthouse Pharmaceuticals.
- Polished.com Inc. (NYSE: POL) surged 30% to $0.6955 after the company's board of directors responded to a 13D filing from Morgan Dempsey.
- BuzzFeed, Inc. (NASDAQ: BZFD) shares climbed 25.8% to $2.6311, gaining for the second day, after reports surfaced about its deal with Facebook parent Meta Platforms Inc yesterday.
- RedHill Biopharma Ltd. (NASDAQ: RDHL) gained 25% to $0.2309. RedHill received USPTO notice of allowance for a patent covering Phase 3-stage RHB-204 for the treatment of NTM disease.
- VivoPower International PLC (NASDAQ: VVPR) climbed 24.6% to $0.6095.
- Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 21.5% to $0.2359.
- Worksport Ltd. (NASDAQ: WKSP) surged 20.8% to $1.51.
- Nuvve Holding Corp. (NASDAQ: NVVE) climbed 18.4% to $1.8701.
- Remark Holdings, Inc. (NASDAQ: MARK) climbed 17.5% to $1.54. Remark Holdings announced partnership with AAEON to 'simplify the delivery of AI-driven video analytics.'
- Guardforce AI Co., Limited (NASDAQ: GFAI) rose 16.5% to $0.28 after jumping 14% on Thursday.
- NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) gained 16.2% to $15.75. NewAmsterdam Pharma recently announced topline results from ROSE2 Phase 2 trial evaluating obicetrapib in combination with ezetimibe as an adjunct to high-intensity statin therapy.
- Icosavax, Inc. (NASDAQ: ICVX) gained 15.4% to $11.44.
- Freight Technologies, Inc. (NASDAQ: FRGT) rose 14.4% to $0.38 after jumping 15% on Thursday.
- Wearable Devices Ltd. (NASDAQ: WLDS) gained 14.3% to $0.62. Wearable Devices recently named Tamar Fleisher as Chief Operating Officer.
- Axos Financial, Inc. (NYSE: AX) climbed 14.3% to $48.06 after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $47 to $50.
- MicroCloud Hologram Inc. (NASDAQ: HOLO) shares gained 13% to $9.95. MicroCloud Hologram, on Thursday, announced the launch of a Holographic Brain-Computer Interface(BCI) data acquisition system.
- Amesite Inc. (NASDAQ: AMST) gained 13% to $0.3254.
- Inozyme Pharma, Inc. (NASDAQ: INZY) gained 12% to $2.35.
- American Express Company (NYSE: AXP) climbed 9.9% to $171.34 after the company issued FY23 EPS guidance above estimates and increased its quarterly dividend.
- Freightos Limited (NASDAQ: CRGO) shares rose 9.9% to $11.53. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I Acquisition Corp.
- Farfetch Limited (NYSE: FTCH) gained 9.7% to $6.89.
- GeoVax Labs, Inc. (NASDAQ: GOVX) shares rose 9.2% to $0.8199 after dropping 32% on Thursday. GeoVax recently received a notice of allowance for its zika vaccine patent.
- Autoliv, Inc. (NYSE: ALV) gained 7.8% to $91.57 after the company reported better-than-expected Q4 EPS results.
- L3Harris Technologies, Inc. (NYSE: LHX) climbed 7.7% to $211.79 after the company reported better-than-expected Q4 adjusted EPS and sales results and issued FY23 adjusted EPS and revenue guidance above estimates.
Losers
- Nemaura Medical Inc. (NASDAQ: NMRD) shares dipped 37.1% to $1.80 after the company announced pricing of a roughly $8.4 million registered direct offering and concurrent private placement.
- Bridger Aerospace Group Holdings, LLC (NASDAQ: BAER) dropped 30% to $13.09. Bridger closed merger agreement with Jack Creek Investment Corp on Tuesday.
- COMSovereign Holding Corp. (NASDAQ: COMS) fell 24.5% to $0.0867 after jumping over 58% on Thursday.
- ContraFect Corporation (NASDAQ: CFRX) fell 24.1% to $0.0696 after dropping 8% on Thursday.
- WiSA Technologies, Inc. (NASDAQ: WISA) dropped 18.1% to $9.09. WiSA Technologies announced a 1-for-100 reverse stock split.
- FLJ Group Limited (NASDAQ: FLJ) fell 14.3% to $1.67.
- Aspen Aerogels, Inc. (NYSE: ASPN) dropped 13.2% to $9.34.
- Alvarium Tiedemann Holdings, Inc. (NASDAQ: ALTI) declined 12.1% to $11.41.
- Altamira Therapeutics Ltd. (NASDAQ: CYTO) fell 12% to $2.80 after the company issued a business update.
- Eastern Bankshares, Inc. (NASDAQ: EBC) dropped 11.7% to $15.53 after the company reported worse-than-expected Q4 EPS results.
- World Acceptance Corporation (NASDAQ: WRLD) declined 10.8% to $96.68 after BMO Capital maintained an Underperform rating on the stock and lowered its price target from $46 to $32.
- Tuniu Corporation (NASDAQ: TOUR) fell 10.4% to $2.5625.
- NetScout Systems, Inc. (NASDAQ: NTCT) dropped 9.6% to $32.58. NetScout Systems recently reported better-than-expected Q3 EPS and sales results.
- California Resources Corporation (NYSE: CRC) declined 8.7% to $43.67. California Resources said Appellate Court issued preliminary order reinstating suspension of Kern County's ability to rely on existing EIR.
- Genelux Corporation (NASDAQ: GNLX) fell 8.1% to $5.65. Genelux announced pricing of $15 million initial public offering of 2.5 million shares of common stock at a price of $6 per share.
- Biotricity, Inc. (NASDAQ: BTCY) shares dropped 7.5% to $0.8176 after jumping 18% on Thursday. Biotricity signed a distribution agreement with top 5 distributor for its cardiac monitoring solutions.
- Intel Corporation (NASDAQ: INTC) fell 7.2% to $27.92 after the company reported weaker-than-expected results for its fourth quarter and issued soft guidance.
Also Check This Out Bitcoin Falls Below $23,000; Holo Emerges As Top Gainer
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Read the original article on Benzinga
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.